PK150, an analogue of Sorafenib, is an antibiotic that demonstrates oral bioavailability and effective antibacterial activity against multiple pathogenic bacterial strains at submicromolar concentrations. Notably, PK150 exhibits inhibitory effects on Gram-positive bacteria, including Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin intermediate Staphylococcus aureus (VISA), with minimum inhibitory concentrations (MICs) of 0.3 μM for MSSA and 0.3-1 μM for MRSA and VISA. This compound is suitable for research applications aimed at understanding bacterial resistance and developing novel antimicrobial therapies.
PK150, an analogue of Sorafenib, is an antibiotic that demonstrates oral bioavailability and effective antibacterial activity against multiple pathogenic bacterial strains at submicromolar concentrations. Notably, PK150 exhibits inhibitory effects on Gram-positive bacteria, including Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin intermediate Staphylococcus aureus (VISA), with minimum inhibitory concentrations (MICs) of 0.3 μM for MSSA and 0.3-1 μM for MRSA and VISA. This compound is suitable for research applications aimed at understanding bacterial resistance and developing novel antimicrobial therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
